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Surgical treatment decision making in 
breast cancer among Chinese women: 
predicting psychological morbidity
Key Messages
1. Ask women about their pre-
ferred level of involvement in 
breast cancer treatment decision 
making and involve them only 
as much as they wish to be 
involved.
2. Provide information whenever 
necessary to assist women with 
treatment decision making.
3. Effective management of 
physical symptom distress 
helps reduce postoperative 
psychological morbidity.
Hong Kong Med J 2007;13(Suppl 3):S19-22
Introduction
Depression rates following breast cancer (BC) surgery vary from a high of 55% 
reported in Italian women,1 to 14% in South African women,2 to more than 25% 
in Mainland Chinese women.3 Psychological morbidity peaks at 1 to 3 months 
post-surgery,4 and persists for >16 months. Social disruption affects 10% and 
reduced attractiveness affects 22% of women with BC for at least 6 years.5
 Greater psychological morbidity has been primarily associated with body 
image disruption, with morbidity reportedly highest following modified radical 
mastectomy (MRM) and lowest following breast conserving treatment (BCT).6 
Symptom distress, coping, optimism and self-efficacy for coping, mediate cancer 
distress in western studies. Additional predictors include consultation, decision 
making, uncertainty and treatment practices, patient values, expectations and 
beliefs about cancer, and family and community norms and responses.
Methods
This study was conducted from October 2000 to June 2003. Following 
institutional ethics approval, we approached all women receiving surgery for 
stage 0 to IV BC in six regional Hong Kong public hospitals between October 
2001 and January 2003 within 5 days following surgery (baseline). Following 
immediate assessment at baseline, participants were followed up 1 month later. 
Inclusion criteria were age over 19 years and Cantonese fluency. Exclusion criteria 
were linguistic or intellectual difficulties, active Axis I psychiatric diagnosis, or 
uncontrolled metastatic brain disease. Of 480 women, 447 (93%) were available 
and eligible, 405 (91%) gave fully informed consent and completed a baseline 
face-to-face interview assessment. At 1-month post-surgery, these women 
completed a telephone interview outcome assessment.
 The Chinese Health Questionnaire (CHQ12) assessed psychological 
morbidity; higher scores represent greater morbidity. Dispositional optimism 
was assessed using the revised Chinese Life Orientation Test, which comprised 
six items scored on a four-point Likert scale from ‘strongly disagree’ to ‘strongly 
agree’; higher scores reflect greater trait optimism. Dispositions are theoretically 
stable and can be reliably measured at any time. The Chinese Generalized Self-
efficacy Scale (GSeS) was used to measure general self-efficacy. The 10 GSeS 
items are personal-response-oriented, eg “I can solve most problems if I invest 
the necessary effort”, and scored on a four-point Likert scale from ‘exactly true’ to 
‘not at all’; higher scores reflect greater self-efficacy. Among Hong Kong Chinese 
women with BC, factor analyses reveal stable factors.7 Women were asked at 
baseline to rate expected impacts of treatment outcomes (outcome expectation) 
using the modified Breast Cancer Treatment Decision Making Questionnaire. 
The 13 items address expectations of negative surgical impact on respondents’ 
sense of femininity, appearance, sexuality, normality, attractiveness and their 
routine, likelihood of recurrence, additional treatment and reconstruction, speed 
of recovery, partner support and cure.7 To assess treatment decision making 
(TDM) difficulties, women completed eight four-point Likert items scored 
from ‘strongly disagree’ to ‘strongly agree’; six of the items measure perceived 
TDM barriers (eg shocked, couldn’t think what to do), and two measure TDM 
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facilitators (adequacy of time and information); higher 
scores reflect greater TDM difficulties. Women indicated 
perceived degree of TDM involvement as follows: (1) “I 
was not allowed to participate”, (2) “less participation than 
I wanted”, (3) “as much participation as I wanted”, (4) 
“more participation than I wanted”, and (5) “much more 
participation than I wanted”. Women rated satisfaction 
with physician communications using the Chinese version 
of the Medical Information Satisfaction Scale-Revised 
(C-MISS-R). Two four-item sub-scales measure cognitive 
(understanding, expectations, and knowledge) and affective 
(satisfaction, worry, and interpersonal elements) aspects of 
consultations. Items are scored on a five-point Likert scale 
from ‘strongly agree’ to ‘strongly disagree’; higher scores 
reflect greater satisfaction.
 A physical symptom distress measure was derived from 
earlier work and the literature. For each of 14 physical 
symptoms, respondents indicated (0) ‘do not have this 
symptom’, (1) ‘mild’, (2) ‘moderate’, (3) ‘severe’, or (4) ‘very 
severe’. All items are summed, with higher scores indicating 
greater physical symptom distress. Demographic (age, marital 
status, occupation, education) and medical data (surgical type, 
disease stage, BC history, and concurrent treatments) were 
gathered from patients and medical records respectively. All 
measures were gathered at baseline, except that the revised 
Chinese Life Orientation Test and physical symptom distress 
were collected at the 1-month follow-up, and the medical data 
that were collected later from medical records. The outcomes 
were CHQ12 scores at the 1-month follow-up.
Data analysis
Analyses initially examined correlations between baseline 
and consultation variables. Analysis of variance (ANOVA) 
examined differences in CHQ12 baseline scores as a 
function of categorical, including medical, variables. Then, 
correlations identified variables significantly associated 
with follow-up CHQ12 scores. Variation by categorical 
variables was examined using ANOVA. The Wilcoxon rank 
test, t test, and Chi squared test were used for univariate 
comparisons for ranked, continuous, and categorical data. 
Next, correlates with baseline CHQ12 scores were entered 
into forward-entry stepped multivariate linear regression 
models to adjust follow-up CHQ12 scores.
Results
At the 1-month follow-up, 367 of the 405 participating 
women did not differ by demographic or medical criteria, 
surgery type, or disease stage from non-participants. Most 
non-participants were married (82%) and 60% had no 
formal education. Of participants, 33% had only primary 
and 56% secondary education, most (79%) were married, 
the age range was 28 to 79 years (mean, 51.8; standard 
deviation [SD], 11.1 years). Among those whose cancer 
staging information was available, 18% had stage 0 disease, 
28% had stage I, and 49% stage II.
 Self-efficacy, optimism, and consultation satisfaction 
were high. Mean scores for outcome expectation were 
modest, while mean TDM difficulties scores fell into the 
second lowest quartile. Physical symptom distress was 
slightly higher in women on active treatment, but overall 
this was quite low.
Prevalence of psychological morbidity
At baseline, 28% of women met case criteria for mild, and 
42% for moderate/severe morbidity (Table 1). At the 1-
month follow-up, 32% women met criteria for mild, and 
36% for moderate/severe psychological morbidity: 7% fewer 
women reported moderate/severe distress and 3.5% more 
reported no distress compared to the baseline. To exclude 
the possibility of inflated distress due to contamination of 
CHQ12 items addressing physical symptoms of distress 
(pressure in the chest, palpitations, headaches) from 
treatment side-effects, CHQ12 scores were recalculated 
to exclude three physical symptom items. No significant 
changes resulted in the proportions of cases and non-cases 
(Table 1).
Psychological morbidity predictors
Baseline CHQ12 scores were unrelated to type of 
Chinese Health 
Questionnaire
(CHQ12)
Total baseline 
sample (A) [n=405]
No. (%)
Baseline sample with 
matching outcome data (B) 
[n=367]
No. (%)
Lost to follow-up 
(C=A-B)
No. (%)
Outcome (D) 
[n=367]
No. (%)
% Change 
(E=D-B)
No. (%)
CHQ12 score*
Low (0-5) 120 (29.6) 106 (28.9) 14 (0.3) 119 (32.4) 13 (3.5)
Mild (6-10) 114 (28.1) 105 (28.6) 9 (0.2) 117 (31.9) 12 (3.3)
Moderate/severe (>10) 171 (42.2) 156 (42.5) 15 (0.3) 131 (35.7) -25 (6.8)
Pro-rated CHQ12 score
Low (0-5) - 108 (29.4) - 125 (34.1) 17 (4.6)
Mild (6-10) - 103 (28.1) - 112 (30.5) 9 (2.4)
Moderate/severe (>10) - 156 (42.5) - 130 (35.4) -26 (7.1)
Table 1.  Change in psychological morbidity from baseline to outcome
* The number of subjects with lower CHQ12 scores at outcome than at baseline is 186. The number of subjects with higher CHQ12 scores at outcome than 
at baseline is 143. The number of subjects with no change is 38 (Z= -2.911, P<0.004). Follow-up CHQ12 scores significantly correlated with baseline CHQ12 
scores (r=0.570), age (r= -0.186), employment status (r= -0.161), outcome expectation (r=0.434), and TDM difficulties (r=0.339), and at follow-up, with 
optimism (r= -0.369) active chemotherapy (r=0.143), and physical symptom distress (r=0.625)
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surgery, disease stage, place of surgery, demographic 
factors, or degree of TDM involvement. Significant 
correlations emerged with perceived outcome expectation 
(r=0.506), TDM difficulties (r=0.445), age (r= –0.218), 
C-MISS-R (r= –0.209), and GSeS (r= –0.330). In turn, 
TDM difficulties correlated with outcome expectation 
(r=0.495) and the affective (r= –0.333) and cognitive (r= 
–0.206) domains of the C-MISS-R. Multiple regression 
of baseline CHQ12 on all of the above variables retained 
only outcome expectation, TDM difficulties, and GSeS 
(adjusted R2=0.312). Mean follow-up CHQ12 scores were 
unrelated to surgery type (BCT=9.5, MRM=9.4, MRM 
plus breast reconstruction=8.9), disease stage, hospital, 
and demographic factors. Women whose perceived TDM 
involvement was “as much as I desired” had significantly 
lower CHQ12 scores at follow-up (mean, 8.8) than 
women perceiving “I was not allowed to participate at all” 
(mean, 14.7) [F=6.702, df=3, P<0.001, Bonferroni post 
hoc difference= –5.96, P=0.011]. No underlying variable 
identified women falling into the ‘no participation’ group.
 In Table 2, model 1 examined predictors of outcome 
CHQ12 after adjustment for demographic, medical, 
treatment, and dispositional factors. Before entering physical 
symptom distress and optimism, outcome expectation was 
the strongest predictor. Model 2 examined if psychological 
distress at baseline predicted follow-up physical symptom 
distress after adjustment for age, surgery type, and tumour 
stage. Physical symptom distress was predicted by current 
chemotherapy, baseline CHQ12, and radiotherapy. Model 
3 adjusted for the contribution of baseline CHQ12 on 
physical symptom distress, by adding baseline CHQ12 
and nodal status into the output from model 1; only TDM 
difficulties was ejected. This model accounted for 60.5% 
of variance. However the contributions to R2 change of 
nodal status and outcome expectation were marginal. A 
forced entry regression confirmed both variables to be non-
significant. The amended model 3 accounted for 58.5% 
of variance in follow-up CHQ12 scores. Only 25 women 
attended a support group, too few to meaningfully enter 
into the multivariate model. We therefore used a t test to 
compare women attending with those not attending (mean 
follow-up CHQ12 scores, 11.36 vs 9.24), but the difference 
in follow-up CHQ12 scores was non-significant (t= –1.62, 
df=364, P=0.106).
Discussion
Treatment decision making difficulties and outcome 
expectation strongly predicted postoperative and outcome 
psychological morbidity, after adjustment for disposition 
and coping efficacy. Consultations, mediated by TDM-
related factors, can exacerbate baseline distress, in turn 
mediating adjustment 1 month postoperatively. Physical 
symptom distress, accounting for most variance in outcome 
CHQ12, was itself predicted by active treatment and 
baseline CHQ12.
 Paradoxically, chemotherapy enhanced physical 
symptom distress, but lowered follow-up psychological 
morbidity. Hong Kong Chinese women may feel that they 
are receiving additional treatment and thus feel reassured 
despite the side-effects. We did not find similar reports on 
western patients.
 These data suggest clinicians should assess preferred 
TDM involvement at the initial consultation with Chinese 
women with BC. Most Chinese women prefer shared TDM, 
Model Step R2 change Adjusted R2 b coefficient P value
Model 1* (5 steps)
Physical symptoms 1 0.397 0.395 0.607 <0.001
Optimism 1+2 0.710 0.465 -0.179 <0.001
Outcome expectation 1+2+3 0.036 0.500 0.158 <0.001
Chemotherapy‡ 1+2+3+4 0.020 0.519 -0.164 <0.001
TDM difficulties§ 1+2+3+4+5 0.007 0.525 0.100 0.018
Model 2† (3 steps)
Chemotherapy‡ 1 0.120 0.117 0.289 <0.001
Baseline CHQ12 1+2 0.055 0.160 0.231 <0.001
Radiotherapy‡ 1+2+3 0.014 0.180 0.119 0.026
Model 3 (6 steps)
Physical symptoms 1 0.397 0.395 0.565 <0.001
Baseline CHQ12 1+2 0.156 0.550 0.352 <0.001
Optimism 1+2+3 0.022 0.572 -0.138 <0.001
Chemotherapy‡ 1+2+3+4 0.014 0.585 -0.142 <0.001
Nodal status§ 1+2+3+4+5 0.011 0.600 0.106 0.004
Outcome expectation§ 1+2+3+4+5+6 0.006 0.605 0.093 0.026
Table 2.  Forward entry stepwise multiple regression models of the Chinese Health Questionnaire (CHQ12) [models 1 and 3] and 
physical symptom distress (model 2) on predictors
* Excluded variables in model 1 are age, employment status, diagnosis, consultation satisfaction (Chinese version of the Medical Information Satisfaction Scale-
Revised), treatment decision making (TDM) participation satisfaction, self-efficacy (Chinese Generalised Self-efficacy Scale), and radiotherapy
† All variables were retained in model 2
‡ Currently active treatment
§ Variables contributing <0.01 change to the R2 value. Despite being statistically significant, these variables were not considered meaningful additions to the 
model and were not considered in interpretation
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one third prefer to decide alone or with their family while 
others prefer the surgeon to decide.8 Women may need help, 
or support, to decide treatment. Decision making support 
through treatment recommendations, accurate information 
on appearance outcomes and information about expected 
symptoms following surgery is desirable. Psychological 
distress at 1 month post-surgery should be sensitive to 
interventions providing personalised support around 
expected symptoms and decision making, and by preparation 
for physical symptoms. Minimising opportunities for 
misattribution helps reduce unnecessary anxiety. Interactions 
with other women who have successfully completed BC 
treatments are likely to be particularly beneficial. Chinese 
women having significant difficulty with TDM should be 
considered at high risk of later psychological distress.
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